EGFR and non-small cell lung carcinoma: Mutations of exon 21 Leu858Arg and exon 19 deletion are generally sensitive to all generations of EGFR-TKI, but the effect and benefit of EGFR-TKI in NSCLC harboring uncommon or compound EGFR mutations is less clear.